 Connection
Shelley Crary to Female
This is a "connection" page, showing publications Shelley Crary has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.409 |
|
|
|
-
Mack JM, Pierce CD, Richter GT, Spray BJ, Nicholas R, Lewis PS, Becton D, Crary SE. Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography. Pediatr Blood Cancer. 2021 02; 68(2):e28824.
Score: 0.045
-
Mack JM, Verkamp B, Richter GT, Nicholas R, Stewart K, Crary SE. Effect of sirolimus on coagulopathy of slow-flow vascular malformations. Pediatr Blood Cancer. 2019 10; 66(10):e27896.
Score: 0.040
-
Jeffreys SM, Levy RA, Crary SE. Autoimmune Lymphoproliferative Syndrome Masquerading as Posttransplant Lymphoproliferative Disorder. J Pediatr Hematol Oncol. 2018 07; 40(5):e305-e308.
Score: 0.038
-
Mack JM, Richter GT, Crary SE. Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series. Lymphat Res Biol. 2018 06; 16(3):278-281.
Score: 0.037
-
Mack JM, Richter GT, Becton D, Salem O, Hill SEM, Crary SE. Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations. Pediatr Blood Cancer. 2018 06; 65(6):e27008.
Score: 0.037
-
Roy SM, Buchanan GR, Crary SE. Splenectomy in children with "mild" hereditary spherocytosis. J Pediatr Hematol Oncol. 2013 Aug; 35(6):430-3.
Score: 0.027
-
Crary SE, Ramaciotti C, Buchanan GR. Prevalence of pulmonary hypertension in hereditary spherocytosis. Am J Hematol. 2011 Dec; 86(12):E73-6.
Score: 0.024
-
Crary SE, Hall K, Buchanan GR. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. Pediatr Blood Cancer. 2011 Apr; 56(4):615-9.
Score: 0.022
-
Crary SE, Troendle S, Ahmad N, Buchanan GR. Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis. Pediatr Blood Cancer. 2010 Oct; 55(4):684-9.
Score: 0.022
-
Crary SE, Buchanan GR, Drake CE, Journeycake JM. Venous thrombosis and thromboembolism in children with osteomyelitis. J Pediatr. 2006 Oct; 149(4):537-41.
Score: 0.017
-
Tran AD, Waller E, Mack JM, Crary SE, Citla-Sridhar D. Mental health in persons with von Willebrand disease in the United States - a large national database study. J Thromb Haemost. 2024 Jun; 22(6):1583-1590.
Score: 0.014
-
Mack JM, Frankowski S, Verkamp B, Crary SE, Spray B, Crawley L, Saccente S, Neville KA. Pupil Size and Reactivity in Pediatric Patients With Sickle Cell Disease. J Pediatr Hematol Oncol. 2023 01 01; 45(1):e44-e47.
Score: 0.012
-
Blatt J, Finger M, Price V, Crary SE, Pandya A, Adams DM. Cancer Risk in Klippel-Trenaunay Syndrome. Lymphat Res Biol. 2019 12; 17(6):630-636.
Score: 0.010
-
Grace RF, Shimano KA, Bhat R, Neunert C, Bussel JB, Klaassen RJ, Lambert MP, Rothman JA, Breakey VR, Hege K, Bennett CM, Rose MJ, Haley KM, Buchanan GR, Geddis A, Lorenzana A, Jeng M, Pastore YD, Crary SE, Neier M, Neufeld EJ, Neu N, Forbes PW, Despotovic JM. Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes. Am J Hematol. 2019 07; 94(7):741-750.
Score: 0.010
-
Samanta D, Ramakrishnaiah R, Crary SE, Sukumaran S, Burrow TA. Multiple Autoimmune Disorders in Aicardi-Gouti?res Syndrome. Pediatr Neurol. 2019 07; 96:37-39.
Score: 0.010
-
Grace RF, Despotovic JM, Bennett CM, Bussel JB, Neier M, Neunert C, Crary SE, Pastore YD, Klaassen RJ, Rothman JA, Hege K, Breakey VR, Rose MJ, Shimano KA, Buchanan GR, Geddis A, Haley KM, Lorenzana A, Thompson A, Jeng M, Neufeld EJ, Brown T, Forbes PW, Lambert MP. Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. Am J Hematol. 2018 07; 93(7):882-888.
Score: 0.009
-
Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Jason Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter SD, Sharma M, Davidoff AM, Nottage K, Bernabe K, Wilson DB, Dutta S, Glader B, Crary SE, Dassinger MS, Dunbar L, Islam S, Kumar M, Rescorla F, Bruch S, Campbell A, Austin M, Sidonio R, Blakely ML, Rice HE. Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia. J Pediatr Surg. 2016 Jan; 51(1):122-7.
Score: 0.008
-
Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA. Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. J Clin Pharmacol. 2016 Mar; 56(3):298-306.
Score: 0.008
-
Rice HE, Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter S, Sharma M, Davidoff AM, Nottage K, Bernabe K, Wilson DB, Dutta S, Glader B, Crary SE, Dassinger MS, Dunbar L, Islam S, Kumar M, Rescorla F, Bruch S, Campbell A, Austin M, Sidonio R, Blakely ML. Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry. Am J Hematol. 2015 Mar; 90(3):187-92.
Score: 0.007
-
Plummer ES, Crary SE, McCavit TL, Buchanan GR. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. Pediatr Blood Cancer. 2013 Nov; 60(11):1747-52.
Score: 0.007
-
Chen KS, Neunert CE, Crary SE, Buchanan GR. Hemolytic non-uremic syndrome. Pediatr Blood Cancer. 2012 Jul 15; 59(1):167-9.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|